Atlas Trials

Lymphoblastic Leukemia, Acute Adult

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lymphoblastic Leukemia, Acute Adult

RecordFirmDate
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia (NCT05429905)KK Women's and Children's Hospital2022-07-18
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol (NCT05648019)KK Women's and Children's Hospital2022-03-15
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (NCT05043571)National University Hospital, Singapore2021-09-08
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. (NCT05038696)National University Hospital, Singapore2021-04-28
Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) (NCT04554485)Institute of Hematology and Blood Transfusion, Czech Republic2019-05-09
Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT03155191)Takara Bio Inc.2017-06-01
Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL (NCT02766868)Shanghai Jiao Tong University School of Medicine2016-01-01
Expanded Access Program for OOS Obe-cel (NCT06799221)Autolus Limited

Track Lymphoblastic Leukemia, Acute Adult automatically

Every clearance here is in the API, with alerts when new ones post.